Establishment Labs
ESTA • NASDAQ
Establishment Labs is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Fillipo Peter Caldini, with a market cap of $1.6B.
CEOFillipo Peter Caldini
Next Earnings
Upcoming earnings announcement for Establishment Labs
Date
Wednesday, May 6, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.34
Revenue Estimate
$57.5M
Earnings History
Past 12 earnings reports for Establishment Labs
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 24, 2026 | Q4 2025 | -$0.09Est: -$0.22 | +59.1% | $64.6MEst: $64.1M | +0.8% |  10-K |
| Nov 5, 2025 | Q3 2025 | -$0.38Est: -$0.52 | +26.9% | $53.8MEst: $52.2M | +3.1% | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.57Est: -$0.55 | -3.6% | $51.3MEst: $51.3M | -0.0% | 10-Q |
| May 7, 2025 | Q1 2025 | -$0.70Est: -$0.63 | -11.1% | $41.4MEst: $44.5M | -6.9% | 10-Q |
| Feb 26, 2025 | Q4 2024 | -$0.98Est: -$0.66 | -48.5% | $44.5MEst: $44.5M | +0.1% | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.59Est: -$0.61 | +3.3% | $40.2MEst: $40.5M | -0.6% | 10-Q |
| Aug 6, 2024 | Q2 2024 | -$0.62Est: -$0.51 | -21.6% | $44.1MEst: $43.1M | +2.4% | 10-Q |
| May 8, 2024 | Q1 2024 | -$0.58Est: -$0.67 | +13.4% | $37.2MEst: $36.0M | +3.2% | 10-Q |
| Feb 28, 2024 | Q4 2023 | -$0.79Est: -$0.91 | +13.2% | $31.6MEst: $31.5M | +0.3% | 10-K |
| Nov 7, 2023 | Q3 2023 | -$1.12Est: -$0.80 | -40.0% | $38.5MEst: $40.5M | -4.9% | — |
| Aug 8, 2023 | Q2 2023 | -$0.65Est: -$0.68 | +4.4% | $48.6MEst: $47.3M | +2.8% | 10-Q |
| May 8, 2023 | Q1 2023 | -$0.48Est: -$0.68 | +29.4% | $46.5MEst: $45.5M | +2.4% | — |